Hematology

Cancer Summaries and Commentaries™: Clinical Updates in MPNs from the Summer Meetings

Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?

B-Cell Tumor Board: Rendering Real World Personalized Treatment Plans in CLL/SLL and MCL Through the Lens of Emerging BTKi Evidence

Community Practice Connections™: Multidisciplinary Strategies for Improving Outcomes in CML from Frontline Care… and Beyond!

Myeloma Management Considerations: Applying the Evidence With Monoclonal Antibody Based Regimens

New Horizons in Multiple Myeloma Treatment – Selection and Sequencing From Newly Diagnosed to Relapsed/Refract...

Crucial Conversations in R/R Multiple Myeloma: Nursing Strategies to Optimize Patient Communication and Improve Outcomes

Community Practice Connections™: Illuminating the Crossroads of Precision Medicine and Targeted Treatment Options in AML

GlobaOncology Town Hall™: Primary Investigators Present Key Abstracts in the Management of B-Cell Lymphomas with BTK Inhibitors

Oncology Briefings™: Coordinating the Long-Term Management of Patients With Multiple Myeloma Between Primary Care and Oncology Practices

Community Practice Connections: 7th Annual School of Nursing Oncology™

6th Annual Precision Medicine Symposium: An Illustrated Tumor Board

Oncology Consultations®: Community and Academic Perspectives on PNH Management – How Do You Do It?

Applying New Evidence in Multiple Myeloma Care from Frontline to R/R Disease

Community Oncology Connections™: Overcoming Clinical Challenges and Embracing New Opportunities in the Management of Multiple Myeloma

Cases and Conversations™: Applying Guidelines to Practice for the Management of Paroxysmal Nocturnal Hemoglobinuria

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

Oncology Briefings™: Case Discussions in Smoldering Myeloma—To Treat or Not to Treat?

Community Practice Connections™: How Can We Optimize the Real World Application of BCMA-Targeted Therapies for Our Patients with R/R Multiple Myeloma?

Medical Crossfire®: How Has the Nurse’s Role Evolved in the Management of Pediatric Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas?

Oncology Briefings™: Selecting Therapy for Patients with Heavily Pretreated Myeloma Based on Patient and Disease-Specific Factors

Focusing on Key Updates on the Outlook of Acute Lymphocytic Leukemia (ALL) Management

Understanding the Recent Developments in Myelodysplastic Syndromes (MDS)

Oncology Town Hall™: Primary Investigators Present Key Abstracts in CLL from San Diego

Experts Address the Hottest Topics in AML: Considerations on FLT3, IDH1/2, TP53, Maintenance, Novel Combinations and Beyond!

Real-World Applications of Asparaginase Formulations in ALL and LBL From Pediatric/AYA to Adult Treatment: Maximizing Clinical Benefits Through Multidisciplinary Care

Experts Address the Hottest Topics in AML: Considerations on FLT3, IDH1/2, TP53, Maintenance, Novel Combinations and Beyond!

Medical Crossfire®: Bridging Expert Guidance and Evidence-Based Recommendations in the Treatment of AYA and Adult ALL

Medical Crossfire®: Bridging Expert Guidance and Evidence-Based Recommendations in the Treatment of AYA and Adult ALL

How Do We Treat GVHD Today…And Tomorrow? Treatment Algorithms for Key Decision Points in Prophylaxis Care, Acute, and Chronic Disease